Trial NCT03028129

View at ClinicalTrials.gov 
Org. Study IDs: U1111-1189-0829

Last trial update was posted on 2019-10-25

MeSH Interventions

Anti-Bacterial Agents Isoniazid

MeSH Conditions

Tuberculosis Tuberculosis, Pulmonary

Other Conditions

Antibiotic Prophylaxis

Stopping Reasons

Interim analysis showed efficacy less than 2.5%.

Limitations And Caveats

Loss to follow-up Interruption of the study Arms presented differential group allocation Statistical power to detect the primary endpoint was 73%, lower than estimated in our sample size calculation

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID